Format

Send to

Choose Destination
See comment in PubMed Commons below
Clin Nephrol. 2012 May;77(5):358-65.

The effect of combined calcium and cholecalciferol supplementation on bone mineral density in elderly women with moderate chronic kidney disease.

Author information

1
University of Washington, Division of Nephrology and Kidney Research Institute, Seattle, WA, USA.

Abstract

AIMS:

To examine the effect of combined calcium and vitamin D3 supplementation on bone mineral density (BMD) inpatients with chronic kidney disease (CKD).

METHODS:

We performed a post-hoc analysis of the DECALYOS II, a 2-year randomized, double-blind, placebo-controlled study of 610 women randomized to: calcium-vitamin D3 fixed combination, calcium plus vitamin D3 separate combination, or placebo. Both active treatment groups received the same daily amount of calcium (1,200 mg) and vitamin D3 (800 IU). BMD of the distal radius was measured by single X-ray absorptiometry at baseline, 12 and 24 months.

RESULTS:

At baseline 47.2%, 36.4% and 16.4% of the study population had an eGFR ≥ 60, 45 -59, and < 45 ml/min/1.73 m2, respectively. Both active regimens vs. placebo markedly increased serum 25-hydroxyvitamin D levels from baseline in all eGFR groups (p 0.22 for all time points).

CONCLUSION:

Combined calcium and vitamin D3 supplementation was effective in reducing rate of BMD loss in women with moderate CKD.

PMID:
22551881
PMCID:
PMC4030712
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Dustri-Verlag Dr. Karl Feistle GmbH & Co. KG Icon for PubMed Central
    Loading ...
    Support Center